A Surgical Simulation Study to Evaluate the Safety of a Device Mechanism as Treatment for Vaginal Apical Prolapse
This study has been completed.
Sponsor:
Ethicon, Inc.
Information provided by:
Ethicon, Inc.
ClinicalTrials.gov Identifier:
NCT00965952
First received: August 25, 2009
Last updated: February 9, 2010
Last verified: February 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this pilot study is to perform a procedure to evaluate the safety of the placement of a new device (known as the VFIX device).
| Condition |
|---|
|
Pelvic Organ Prolapse |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | A Prospective, Observational Surgical Simulation Study to Evaluate the Safety of the VFIX Device Mechanism as Treatment for Vaginal Apical Prolapse |
Resource links provided by NLM:
Further study details as provided by Ethicon, Inc.:
Primary Outcome Measures:
- Incidence of subjects without any bowel entrapment between the vagina and the right SSL in subjects that the surgeon declares he would have deployed the V-Fix device [ Time Frame: Intraoperative ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
- Incidence of subjects without any bladder entrapment or traversing of the peritoneal cavity between the vagina and the right or left SSL in subjects that the surgeon declares he would have deployed the V-Fix device [ Time Frame: Intraoperative ] [ Designated as safety issue: Yes ]
- Incidence of subjects without any bowel entrapment between the vagina and the left SSL in subjects that the surgeon declares he would have deployed the V-Fix device [ Time Frame: Intraoperative ] [ Designated as safety issue: Yes ]
| Enrollment: | 49 |
| Study Start Date: | July 2009 |
| Study Completion Date: | December 2009 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
In this study, the surgeon will not use the actual V-Fix device. Instead, the surgeon will use a routine operating room instrument, which is similar to the size and shape of the V-Fix device to mimic the placement of the VFIX device by using the routine operating room instrument to push the top of your vagina towards the ligament.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
hospital referrals
Criteria
Inclusion Criteria:
- Age greater than or equal to 18 years.
- Subjects with apical support prolapse in whom the surgeon may consider a surgical procedure to correct level 1 support, with "C" or "D" descent at least halfway down the vaginal length (i.e. uterus and cervix or the vaginal vault in hysterectomised subjects), and having laparoscopy or abdominal surgery (additional surgery e.g. tubal ligation or ovarian cystectomy is also allowed).
- Vaginal examination during the screening visit confirms that the lateral fornix of the vagina can reach both the left and right SSL and therefore the surgical simulation can be performed.
- The investigator considers that the subject is medically fit enough to receive extended anaesthesia of approximately 15 minutes, to complete the additional anatomical observation study procedures.
- Subjects agree to participate in the study and document this agreement by signing the Ethics Committee approved informed consent.
Exclusion Criteria:
- None
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00965952
Locations
| Australia, New South Wales | |
| North Shore Private Hospital | |
| Sydney, New South Wales, Australia | |
| St George Private Hospital | |
| Sydney, New South Wales, Australia | |
| Australia, Victoria | |
| Royal Women's Hospital | |
| Melbourne, Victoria, Australia | |
| Frances Perry House | |
| Melbourne, Victoria, Australia | |
Sponsors and Collaborators
Ethicon, Inc.
Investigators
| Study Director: | David Robinson, MD | Ethicon, Inc. |
More Information
No publications provided
| Responsible Party: | David Robinson MD/Medical Director, Ethicon |
| ClinicalTrials.gov Identifier: | NCT00965952 History of Changes |
| Other Study ID Numbers: | 300-08-009 |
| Study First Received: | August 25, 2009 |
| Last Updated: | February 9, 2010 |
| Health Authority: | Australia: Human Research Ethics Committee |
Additional relevant MeSH terms:
|
Prolapse Pelvic Organ Prolapse Pathological Conditions, Anatomical |
ClinicalTrials.gov processed this record on May 19, 2013